Kura Oncology

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kura Oncology and other ETFs, options, and stocks.

About KURA

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. 

CEO
Troy E. Wilson
CEOTroy E. Wilson
Employees
121
Employees121
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
121
Employees121

KURA Key Statistics

Market cap
839.51M
Market cap839.51M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.25M
Average volume1.25M
High today
$12.61
High today$12.61
Low today
$12.25
Low today$12.25
Open price
$12.41
Open price$12.41
Volume
1.18M
Volume1.18M
52 Week high
$21.10
52 Week high$21.10
52 Week low
$10.41
52 Week low$10.41

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

KURA Earnings

-$0.54
-$0.36
-$0.18
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.